RMD took a noticeable 4.6% hit yesterday as the CFO sold a few more shares, never a good sign, but conversely not always a reason to “run-away”. We still like the sleep disorder business but with fears towards growth names and a CFO selling we are in no hurry to average our position, another 5-6% lower and we may consider increasing our small position slightly.
MM will consider averaging our position into fresh 2022 lows
Add To Hit List
